Thursday, January 29, 2015 8:06:28 AM
JANUARY 29, 2015 NEWS 0 LIKES
Breakfast Symposium "The novelty - CytoSorb® therapy in patients with cardiac surgery and CPB"
Also at the 44th Annual Meeting of the German Society for Thoracic and Vascular Surgery in Freiburg, we are present with a booth (A10) and look forward also to invite you to the following symposium - due to the early time waiting for a delicious breakfast snack for you!
Tuesday, February 10, 2015
07:30 - 08:30 clock, Meeting Room 4
• 07.30 - 08.00 clock
SIRS as a serious complication of cardiac surgery
T. Doenst, Jena
• 08:00 - 08.30 clock
Which patient is benefiting from the CytoSorb® treatment?
K. Carrier, Ulm
http://www.sitzungsplan.de/dgthg2015/
Claudia Weinmann
CYTOSORB AUF DEM DGTHG SYMPOSIUM 8.-11.02.15 IN FREIBURG
ANUARY 29, 2015 NEWS 0 LIKES
Frühstückssymposium “Der Reiz des Neuen – CytoSorb®-Therapie bei Patienten mit herzchirurgischem Eingriff und HLM”
Auch auf der 44. Jahrestagung der Deutschen Gesellschaft für Thorax-, Herz- & Gefäßchirurgie in Freiburg sind wir mit einem Stand (A10) vertreten und freuen uns zudem, Sie zu folgendem Symposium einzuladen – aufgrund der frühen Uhrzeit wartet ein leckerer Frühstückssnack auf Sie!
Dienstag, 10. Februar 2015
07:30 – 08:30 Uhr, Tagungsraum 4
• 07.30 – 08.00 Uhr
SIRS als schwere Komplikation bei kardiochirurgischen Patienten
T. Doenst, Jena
• 08.00 – 08.30 Uhr
Welcher Patient profitiert von der CytoSorb®-Behandlung?
K. Träger, Ulm
http://www.sitzungsplan.de/dgthg2015/
Claudia Weinmann
Recent CTSO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:14:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:30 PM
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:15:22 PM
- CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/13/2023 02:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/11/2023 09:10:44 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM